219 related articles for article (PubMed ID: 36523136)
1. Cardiac Arrest Following Torsades de Pointes Caused by Hypokalemia and Catecholamines in a Patient with Congenital Long QT Syndrome Type 1 After Surgical Aortic Valve Replacement: A Case Report.
Kitaura A; Nakao S; Yuasa H; Tsukimoto S; Nakajima Y
Am J Case Rep; 2022 Dec; 23():e938609. PubMed ID: 36523136
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man.
Guess J; Hubel K; Wiggins A; Madigan CG; Bunin J
Am J Case Rep; 2018 Dec; 19():1515-1518. PubMed ID: 30568157
[TBL] [Abstract][Full Text] [Related]
3. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron.
Orozco BS; Lee SC; Fuchs RT; Fushianes GD; Cole JB
Am J Emerg Med; 2023 Jun; 68():214.e3-214.e6. PubMed ID: 37085406
[TBL] [Abstract][Full Text] [Related]
4. [Drug induced QT prolongation].
Altmann D; Eggmann U; Ammann P
Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia and subsequent torsades de pointes with marked QT prolongation during refeeding.
Nakashima T; Kubota T; Takasugi N; Kitagawa Y; Yoshida T; Ushikoshi H; Kawasaki M; Nishigaki K; Ogura S; Minatoguchi S
Nutrition; 2017 Jan; 33():145-148. PubMed ID: 27544004
[TBL] [Abstract][Full Text] [Related]
6. [An unusual cause of cardiac arrest].
Campana A; Manzo M; Brigante M; Marrazzo N; Melchiorre G
Ital Heart J Suppl; 2003 Jun; 4(6):510-3. PubMed ID: 19400057
[TBL] [Abstract][Full Text] [Related]
7. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
8. Premature atrial contraction induces torsades de pointes in a patient of Takotsubo cardiomyopathy with QT prolongation.
Kawano H; Matsumoto Y; Arakawa S; Satoh O; Hayano M
Intern Med; 2010; 49(16):1767-73. PubMed ID: 20720356
[TBL] [Abstract][Full Text] [Related]
9. Diuretic-induced hypokalaemia inducing torsades de pointes.
Chvilicek JP; Hurlbert BJ; Hill GE
Can J Anaesth; 1995 Dec; 42(12):1137-9. PubMed ID: 8595691
[TBL] [Abstract][Full Text] [Related]
10. Mexiletine effectively prevented refractory Torsades de Pointes and ventricular fibrillation in a patient with congenital type 2 long QT syndrome.
Nakashima R; Takase S; Kai K; Sakamoto K; Tsutsui H
J Cardiovasc Electrophysiol; 2022 Jul; 33(7):1592-1595. PubMed ID: 35488741
[TBL] [Abstract][Full Text] [Related]
11. Long QT syndrome and torsades de pointes complicating mitral valve replacement.
Gilbert S; Singh D; Jesuraj ML
Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S210-S211. PubMed ID: 27751291
[TBL] [Abstract][Full Text] [Related]
12. [A case of cardiac arrest after torsades de pointes due to prolonged QT interval syndrome possibly associated with subarachnoid hemorrhage].
Yamaguchi S; Watanabe K; Mishio M; Okuda Y; Kitajima T
Masui; 1999 Jun; 48(6):644-6. PubMed ID: 10402818
[TBL] [Abstract][Full Text] [Related]
13. Case report: A 56-year-old woman presenting with torsades de pointes and cardiac arrest associated with levosimendan administration and underlying congenital long QT syndrome type 1.
Zha F; Li X; Yin H; Huang D; Du Y; Zhou C
Heliyon; 2024 Apr; 10(8):e29300. PubMed ID: 38644859
[TBL] [Abstract][Full Text] [Related]
14. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
Kawabata M; Hirao K; Takeshi S; Sakurai K; Inagaki H; Hachiya H; Isobe M
J Electrocardiol; 2008; 41(2):117-22. PubMed ID: 18328336
[TBL] [Abstract][Full Text] [Related]
15. A case of short QT-interval postventricular arrhythmia arrest from Torsade De Pointes, a new phenotype, or the result of tachycardia-mediated imbalance.
Ifedili I; Maturana M; Kayali S; Levine Y; Kabra R; Jha SK
J Cardiovasc Electrophysiol; 2024 Mar; 35(3):501-504. PubMed ID: 38174843
[TBL] [Abstract][Full Text] [Related]
16. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
Uvelin A; Pejaković J; Mijatović V
J Anesth; 2017 Jun; 31(3):413-423. PubMed ID: 28229241
[TBL] [Abstract][Full Text] [Related]
17. QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes.
Kaye AD; Volpi-Abadie J; Bensler JM; Kaye AM; Diaz JH
J Anesth; 2013 Aug; 27(4):575-87. PubMed ID: 23412014
[TBL] [Abstract][Full Text] [Related]
18. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
[TBL] [Abstract][Full Text] [Related]
19. Torsades de pointes: a case with multiple variables.
Khan IA; Win MT; Bali AJ; Vasavada BC; Sacchi TJ
Am J Emerg Med; 1999 Jan; 17(1):80-5. PubMed ID: 9928709
[TBL] [Abstract][Full Text] [Related]
20. Severe Torsades de Pointes with acquired QT prolongation.
Narang A; Ozcan C
Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):775-776. PubMed ID: 27154527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
